Skip to main content
Nivolumab Wins First-Line Indication in Metastatic Urothelial Carcinoma
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Nivolumab Wins First-Line Indication in Metastatic Urothelial Carcinoma
User login
Username
Password
Reset your password
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.9
Concept
Lead
score
Cancer
0
1
Thyroid Disease
0
0.68
Peripheral Neuropathy
0
0.21
Chemotherapy
0
0.15
Constipation
0
0.15
Diarrhea
0
0.15
Edema
0
0.15
Fatigue
0
0.15
Hypothyroidism
0
0.15
Nausea
0
0.15
Neuropathy
0
0.15
Pain
0
0.15
Pain Management
0
0.15
Platinum
0
0.15
Pruritus
0
0.15
Resection
0
0.15
Urinary Tract Infection
0
0.15
Edit Tags